Drug Type Single-chain FV antibody fragment |
Synonyms- |
Target |
Action antagonists |
Mechanism P2X4 receptor antagonists(P2X purinoceptor 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Pain | Preclinical | United States | 01 Jul 2025 | |
| Chronic Pain | Preclinical | United States | 01 Jul 2025 | |
| Neuralgia | Preclinical | United States | 01 Jul 2025 | |
| Neuralgia | Preclinical | United States | 01 Jul 2025 |






